Literature DB >> 15565422

[Diagnosis of endolymphatic hydrops using low frequency modulated distortion product otoacoustic emissions].

A Hirschfelder1, E Gossow-Müller-Hohenstein, J Hensel, G Scholz, D Mrowinski.   

Abstract

BACKGROUND: The low frequency modulation of distortion product otoacoustic emissions (DPOAEs) is an objective audiometric method that appears to be a useful tool for the diagnosis of endolymphatic hydrops (EH), e.g. in patients with Menière's disease, or in those who present only some of the symptoms of the disease.
METHOD: Low-frequency modulated DPOAEs were registered in 20 patients with unilateral Menière's disease (13 women and 7 men, aged 40-66 years) and were compared to a control group matched in age and gender. As a diagnostic parameter, the 'modulation index' MI=1/2 MS/DM was used (MS or modulation span, being the difference between the maximal and the minimal DPOAE-amplitude, and DM, being the mean of the suppressed stationary DPOAE-amplitude).
RESULTS: In the patients with unilateral Menière's disease, MI was lower than in the control group. This difference was highly significant. In 56% of the patients' contralateral ears MI was lower than the cut off-value and significantly lower than in the control group, but did not differ significantly from the patients' ipsilateral ears.
CONCLUSION: The registration of low-frequency modulated DPOAEs is comparable to the generally applied transtympanic electrocochleography in its diagnostic validity. The method is fast and non-invasive and could be applied to monitor the course of the disease.

Entities:  

Mesh:

Year:  2005        PMID: 15565422     DOI: 10.1007/s00106-004-1171-4

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  19 in total

1.  Meniere's disease: the incidence of hydrops in the contralateral asymptomatic ear.

Authors:  B J Conlon; W P Gibson
Journal:  Laryngoscope       Date:  1999-11       Impact factor: 3.325

2.  [Communication and personality. Markers for successful leadership].

Authors:  W von Eiff
Journal:  HNO       Date:  2001-01       Impact factor: 1.284

3.  Low-frequency modulation of the 2f1-f2 distortion product otoacoustic emissions in the human ear.

Authors:  G Scholz; A Hirschfelder; T Marquardt; J Hensel; D Mrowinski
Journal:  Hear Res       Date:  1999-04       Impact factor: 3.208

4.  [Automated hearing threshold estimation in newborns using extrapolated DPOAE input/output functions].

Authors:  T Janssen; A Klein; D D Gehr
Journal:  HNO       Date:  2003-06-17       Impact factor: 1.284

5.  The level and growth behavior of the 2 f1-f2 distortion product otoacoustic emission and its relationship to auditory sensitivity in normal hearing and cochlear hearing loss.

Authors:  P Kummer; T Janssen; W Arnold
Journal:  J Acoust Soc Am       Date:  1998-06       Impact factor: 1.840

6.  Diagnosis of endolymphatic hydrops by low-frequency masking.

Authors:  D Mrowinski; G Scholz; S Krompass; K Nubel
Journal:  Audiol Neurootol       Date:  1996 Mar-Apr       Impact factor: 1.854

Review 7.  Diagnostic testing for endolymphatic hydrops.

Authors:  H A Arts; P R Kileny; S A Telian
Journal:  Otolaryngol Clin North Am       Date:  1997-12       Impact factor: 3.346

8.  A review of electrocochleography: instrumentation settings and meta-analysis of criteria for diagnosis of endolymphatic hydrops.

Authors:  F L Wuyts; P H Van de Heyning; M P Van Spaendonck; G Molenberghs
Journal:  Acta Otolaryngol Suppl       Date:  1997

9.  [Intravenous gentamicin therapy in bilateral Menière disease].

Authors:  K Jahnke; D Arweiler
Journal:  Laryngorhinootologie       Date:  1997-09       Impact factor: 1.057

10.  Bilateral electrocochleographic findings in unilateral Menière's disease.

Authors:  D A Moffat; D M Baguley; M L Harries; M Atlas; C A Lynch
Journal:  Otolaryngol Head Neck Surg       Date:  1992-09       Impact factor: 3.497

View more
  5 in total

1.  [Low frequency fluctuating hearing loss without labyrinthine vertigo--a genuine disease? A follow up study after 4 and 10 years].

Authors:  H Schaaf; G Hesse
Journal:  HNO       Date:  2007-08       Impact factor: 1.284

2.  Low-frequency distortion product otoacoustic emission test compared to ECoG in diagnosing endolymphatic hydrops.

Authors:  A Rotter; S Weikert; J Hensel; G Scholz; H Scherer; M Hölzl
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-06       Impact factor: 2.503

3.  Displacements of the organ of Corti by gel injections into the cochlear apex.

Authors:  Alec N Salt; Daniel J Brown; Jared J Hartsock; Stefan K Plontke
Journal:  Hear Res       Date:  2009-02-13       Impact factor: 3.208

4.  Low-frequency modulation of distortion product otoacoustic emissions in humans.

Authors:  Lin Bian; Nicole M Scherrer
Journal:  J Acoust Soc Am       Date:  2007-09       Impact factor: 1.840

5.  Multiple indices of the 'bounce' phenomenon obtained from the same human ears.

Authors:  M Drexl; M Uberfuhr; T D Weddell; A N Lukashkin; L Wiegrebe; E Krause; R Gürkov
Journal:  J Assoc Res Otolaryngol       Date:  2013-11-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.